JP2023518430A5 - - Google Patents
Info
- Publication number
- JP2023518430A5 JP2023518430A5 JP2022556099A JP2022556099A JP2023518430A5 JP 2023518430 A5 JP2023518430 A5 JP 2023518430A5 JP 2022556099 A JP2022556099 A JP 2022556099A JP 2022556099 A JP2022556099 A JP 2022556099A JP 2023518430 A5 JP2023518430 A5 JP 2023518430A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutical composition
- therapeutically effective
- effective dose
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062991996P | 2020-03-19 | 2020-03-19 | |
| US62/991,996 | 2020-03-19 | ||
| PCT/CA2021/050350 WO2021184115A1 (en) | 2020-03-19 | 2021-03-16 | Use of bucillamine in the treatment of infectious diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518430A JP2023518430A (ja) | 2023-05-01 |
| JP2023518430A5 true JP2023518430A5 (cg-RX-API-DMAC7.html) | 2024-02-02 |
Family
ID=77767915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556099A Pending JP2023518430A (ja) | 2020-03-19 | 2021-03-16 | 感染症の治療におけるブシラミンの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230172884A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4121035A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023518430A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230015320A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021184115A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021231421A1 (en) * | 2020-05-13 | 2021-11-18 | The Regents Of The University Of California | Thiol-containing compounds for use in treating coronavirus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025393A (en) * | 1995-09-25 | 2000-02-15 | Santen Pharmaceutical Co., Ltd. | Method for treatment of inflammatory intestinal diseases |
| WO2010014953A1 (en) * | 2008-08-01 | 2010-02-04 | The Regents Of The University Of Colorado, A Body Corporate | Prolonged administration of a dithiol anti-oxidant protects against ventricular remodeling |
| CA2781314A1 (en) * | 2010-01-28 | 2011-08-04 | The Johns Hopkins University | Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| US20110218241A1 (en) * | 2010-03-06 | 2011-09-08 | Cacao Bio-Technologies, Llc | Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
| GB201012889D0 (en) * | 2010-08-02 | 2010-09-15 | Univ Leuven Kath | Antiviral activity of novel bicyclic heterocycles |
| CA2888647A1 (en) * | 2012-11-20 | 2014-05-30 | Revive Therapeutics Inc. | The use of bucillamine in the treatment of gout |
| MX392606B (es) * | 2016-03-17 | 2025-03-24 | Thiogenesis Therapeutics Inc | Composiciones para la liberacion controlada de cisteamina y el tratamiento sistemico de trastornos sensibles a la cisteamina. |
-
2021
- 2021-03-16 US US17/912,597 patent/US20230172884A1/en not_active Abandoned
- 2021-03-16 JP JP2022556099A patent/JP2023518430A/ja active Pending
- 2021-03-16 EP EP21772039.0A patent/EP4121035A4/en not_active Withdrawn
- 2021-03-16 KR KR1020227036230A patent/KR20230015320A/ko not_active Withdrawn
- 2021-03-16 WO PCT/CA2021/050350 patent/WO2021184115A1/en not_active Ceased